With a gain of 100 million from Cominar, businessman George Armoyan acquires 10% of Knight Therapeutics
After making a profit of nearly $100 million in less than two years with Cominar during the pandemic, Montreal businessman George Armoyan is turning his attention to another Quebec company.
Continue ReadingHALIFAX, NS, June 20, 2022 /CNW/ – G2S2 Capital Inc. (“G2S2”) announces today that its wholly owned subsidiary has increased its ownership of trust units (“Units”) of Slate Office REIT (“Slate Office”) to 12.10% of Slate Office’s outstanding Units.
Continue ReadingHALIFAX, NS, June 14, 2022 /CNW/ – G2S2 Capital Inc. (“G2S2”) announces today that its wholly owned subsidiary has increased its ownership of Knight Therapeutics Inc. (“Knight”) to over 10% of Knight’s outstanding common shares.
Continue Reading